1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt structure
|
Common Name | 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt | ||
|---|---|---|---|---|
| CAS Number | 111130-13-3 | Molecular Weight | 509.92 | |
| Density | N/A | Boiling Point | 597.3ºC at 760 mmHg | |
| Molecular Formula | C23H25ClN5NaO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 315ºC | |
Use of 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium saltCGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1]. |
| Name | sodium,N-[5-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-chloro-2-methylphenyl]-1,2,3-triaza-4-azanidacyclopenta-2,5-diene-5-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1]. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 597.3ºC at 760 mmHg |
|---|---|
| Molecular Formula | C23H25ClN5NaO5 |
| Molecular Weight | 509.92 |
| Flash Point | 315ºC |
| Exact Mass | 509.14400 |
| PSA | 125.43000 |
| LogP | 4.72420 |
| Vapour Pressure | 4.11E-15mmHg at 25°C |
| InChIKey | CJDFUZGGLMRUHB-UHFFFAOYSA-M |
| SMILES | CCCc1c(OCCCOc2cc(NC(=O)c3nnn[n-]3)c(C)cc2Cl)ccc(C(C)=O)c1O.[Na+] |
| N-(5-(3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy)-4-chloro-2-methylphenyl)-1H-tetrazole-5-carboxamide monosodium salt |
| N-(3-(3-(4-Acetyl-3-hydroxy-2-n-propylphenoxy)propoxy)-4-chloro-6-methylphenyl)-1H-tetrazole-5-carboxamide |
| 1H-Tetrazole-5-carboxamide,N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy)-4-chloro-2-methylphenyl)-,monosodium salt |